Skip to content

Clinical trials

Terminated Phase 3 trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Status: Terminated Country / region: New Zealand Clear all

118 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20064
20076
20086
20096
20106
201110
20126
20135
20144
20158
20161
20178
201814
201912
20207
20216
20226
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated118

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline7
Hoffmann-La Roche7
Merck Sharp & Dohme LLC6
Pfizer6
Gilead Sciences5
Eli Lilly and Company4
Sanofi4
Janssen Research & Development, LLC3
Lexicon Pharmaceuticals3
Shire3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Crohn Disease10
Alzheimer Disease6
Diabetes Mellitus, Type 26
Arthritis, Rheumatoid5
Carcinoma, Non-Small-Cell Lung5
Cardiovascular Diseases4
Non-alcoholic Fatty Liver Disease4
Stroke4
Bone Marrow Diseases3
Hematologic Diseases3

Trials

Showing 1 to 25 of 118. Each trial links to its page on Pharma Observatory.

18 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.